Expired activity
Please go to the PowerPak homepage and select a course.

B-Cell Maturation Antigen: Promising Target for Relapsed and/or Refractory Multiple Myeloma (Recorded Podcast)

References »

FACULTY

Larry W. Buie, Pharm, BCOP, FASHP
Clinical Pharmacy Manager, Adult Pharmacy Services
Memorial Sloan Kettering Cancer Center
New York, NY


Upon completion of this activity, participants should be better able to:

  • Describe BCMA as a target in relapsed and/or refractory multiple myeloma and the efficacy of BCMA targeted agents being evaluated in clinical trials
  • Recognize the adverse event profiles of anti-BCMA agents and effective management strategies

Back to Top